Yousuke Aoki

1.3k total citations
30 papers, 982 citations indexed

About

Yousuke Aoki is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yousuke Aoki has authored 30 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 18 papers in Radiation and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yousuke Aoki's work include Lung Cancer Diagnosis and Treatment (19 papers), Advanced Radiotherapy Techniques (18 papers) and Lung Cancer Treatments and Mutations (8 papers). Yousuke Aoki is often cited by papers focused on Lung Cancer Diagnosis and Treatment (19 papers), Advanced Radiotherapy Techniques (18 papers) and Lung Cancer Treatments and Mutations (8 papers). Yousuke Aoki collaborates with scholars based in Japan. Yousuke Aoki's co-authors include Atsuya Takeda, Etsuo Kunieda, Naoko Sanuki, Yohei Oku, Toshio Ohashi, Naoyoshi Koike, Yuichiro Tsurugai, Toshiaki Takeda, Takahisa Eriguchi and Hiroshi Handa and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and CHEST Journal.

In The Last Decade

Yousuke Aoki

30 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yousuke Aoki Japan 16 701 463 387 308 147 30 982
J. DeLuca United States 6 1.2k 1.7× 962 2.1× 504 1.3× 325 1.1× 181 1.2× 8 1.5k
Yohei Oku Japan 22 778 1.1× 688 1.5× 531 1.4× 498 1.6× 164 1.1× 43 1.3k
David L. Andolino United States 5 391 0.6× 364 0.8× 196 0.5× 308 1.0× 146 1.0× 7 673
Alessia Guarneri Italy 15 794 1.1× 559 1.2× 377 1.0× 135 0.4× 127 0.9× 43 1.0k
Carol Haddad Australia 11 243 0.3× 336 0.7× 266 0.7× 295 1.0× 113 0.8× 18 636
Merete Paludan Denmark 9 987 1.4× 804 1.7× 466 1.2× 107 0.3× 228 1.6× 13 1.3k
Anders Traberg Denmark 7 873 1.2× 717 1.5× 423 1.1× 116 0.4× 120 0.8× 7 1.2k
Joern Wulf Germany 12 953 1.4× 1.1k 2.3× 605 1.6× 237 0.8× 221 1.5× 16 1.3k
Jian-Kuen Wu Taiwan 7 259 0.4× 299 0.6× 176 0.5× 365 1.2× 120 0.8× 9 568
Alexis Bujold Canada 7 304 0.4× 349 0.8× 217 0.6× 532 1.7× 237 1.6× 13 800

Countries citing papers authored by Yousuke Aoki

Since Specialization
Citations

This map shows the geographic impact of Yousuke Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yousuke Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yousuke Aoki more than expected).

Fields of papers citing papers by Yousuke Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yousuke Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yousuke Aoki. The network helps show where Yousuke Aoki may publish in the future.

Co-authorship network of co-authors of Yousuke Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Yousuke Aoki. A scholar is included among the top collaborators of Yousuke Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yousuke Aoki. Yousuke Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsurugai, Yuichiro, Atsuya Takeda, Naoko Sanuki, et al.. (2024). Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer. Strahlentherapie und Onkologie. 201(8). 779–787. 2 indexed citations
2.
Takeda, Atsuya, Yuichiro Tsurugai, Naoko Sanuki, et al.. (2018). Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy. Journal of Thoracic Disease. 10(1). 247–261. 9 indexed citations
3.
Tsurugai, Yuichiro, Atsuya Takeda, Naoko Sanuki, et al.. (2017). Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias. Radiotherapy and Oncology. 125(2). 310–316. 14 indexed citations
4.
Eriguchi, Takahisa, Atsuya Takeda, Naoko Sanuki, et al.. (2017). Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer. Lung Cancer. 109. 62–67. 25 indexed citations
5.
Eriguchi, Takahisa, Atsuya Takeda, Naoko Sanuki, et al.. (2016). Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer. Journal of Radiation Research. 57(3). 265–272. 11 indexed citations
6.
Takeda, Atsuya, Naoko Sanuki, Yuichiro Tsurugai, Yohei Oku, & Yousuke Aoki. (2016). Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions. Journal of Radiation Research. 57(4). 400–405. 37 indexed citations
7.
Hara, Yu, Atsuya Takeda, Takahisa Eriguchi, et al.. (2015). Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy. Journal of Radiation Research. 57(1). 62–67. 10 indexed citations
8.
Nishimura, Shuichi, Atsuya Takeda, Naoko Sanuki, et al.. (2014). Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors. Journal of Thoracic Oncology. 9(9). 1370–1376. 40 indexed citations
9.
Takeda, Atsuya, Naoko Sanuki, Hirofumi Fujii, et al.. (2013). Maximum Standardized Uptake Value on FDG-PET Is a Strong Predictor of Overall and Disease-Free Survival for Non–Small-Cell Lung Cancer Patients after Stereotactic Body Radiotherapy. Journal of Thoracic Oncology. 9(1). 65–73. 46 indexed citations
10.
Oku, Yohei, Atsuya Takeda, Naoko Sanuki, et al.. (2013). Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: Optimal isodose line fitting to the planning target volume. Practical Radiation Oncology. 4(1). e7–e13. 5 indexed citations
11.
Takeda, Atsuya, Yohei Oku, Naoko Sanuki, et al.. (2012). Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma. Radiotherapy and Oncology. 104(3). 374–378. 30 indexed citations
12.
Takeda, Atsuya, Tatsuji Enomoto, Naoko Sanuki, et al.. (2012). Reassessment of Declines in Pulmonary Function ≥ 1 Year After Stereotactic Body Radiotherapy. CHEST Journal. 143(1). 130–137. 28 indexed citations
13.
Eriguchi, Takahisa, Atsuya Takeda, Naoko Sanuki, et al.. (2012). Acceptable Toxicity After Stereotactic Body Radiation Therapy for Liver Tumors Adjacent to the Central Biliary System. International Journal of Radiation Oncology*Biology*Physics. 85(4). 1006–1011. 64 indexed citations
14.
Takeda, Atsuya, Etsuo Kunieda, Hirofumi Fujii, et al.. (2012). Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer. Lung Cancer. 79(3). 248–253. 47 indexed citations
15.
Oku, Yohei, Atsuya Takeda, Etsuo Kunieda, et al.. (2011). Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Practical Radiation Oncology. 2(1). 46–53. 24 indexed citations
16.
Takeda, Atsuya, Etsuo Kunieda, Toshio Ohashi, et al.. (2011). Severe COPD Is Correlated With Mild Radiation Pneumonitis Following Stereotactic Body Radiotherapy. CHEST Journal. 141(4). 858–866. 66 indexed citations
17.
Takeda, Atsuya, Toshio Ohashi, Etsuo Kunieda, et al.. (2011). The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT). Radiotherapy and Oncology. 101(2). 291–297. 84 indexed citations
18.
Takeda, Atsuya, Etsuo Kunieda, Toshio Ohashi, et al.. (2011). Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiotherapy and Oncology. 101(2). 255–259. 134 indexed citations
19.
Katoh, Osamu, et al.. (1991). Clinical Pharmacology and Toxicity of Low Daily Administration of Oral Etoposide in Advanced Lung Cancer Patients. The Journal of Clinical Pharmacology. 31(12). 1155–1160. 8 indexed citations
20.
Ikai, Atsushi, et al.. (1989). Inhibition of inflammatory proteinase, medullasin, by α2-macroglobulin and ovomacroglobulin. Biochemical and Biophysical Research Communications. 158(3). 831–836. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026